295 related articles for article (PubMed ID: 18165266)
1. Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy.
Lamm ME; Emancipator SN; Robinson JK; Yamashita M; Fujioka H; Qiu J; Plaut AG
Am J Pathol; 2008 Jan; 172(1):31-6. PubMed ID: 18165266
[TBL] [Abstract][Full Text] [Related]
2. Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy.
Gesualdo L; Ricanati S; Hassan MO; Emancipator SN; Lamm ME
J Clin Invest; 1990 Sep; 86(3):715-22. PubMed ID: 2203821
[TBL] [Abstract][Full Text] [Related]
3. Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.
Reily C; Moldoveanu Z; Pramparo T; Hall S; Huang ZQ; Rice T; Novak L; Komers R; Jenkinson CP; Novak J
Am J Physiol Renal Physiol; 2024 May; 326(5):F862-F875. PubMed ID: 38511222
[TBL] [Abstract][Full Text] [Related]
4. Bacterial IgA protease-mediated degradation of agIgA1 and agIgA1 immune complexes as a potential therapy for IgA Nephropathy.
Wang L; Li X; Shen H; Mao N; Wang H; Cui L; Cheng Y; Fan J
Sci Rep; 2016 Aug; 6():30964. PubMed ID: 27485391
[TBL] [Abstract][Full Text] [Related]
5. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
Montinaro V; Esparza AR; Cavallo T; Rifai A
Lab Invest; 1991 Apr; 64(4):508-19. PubMed ID: 2016857
[TBL] [Abstract][Full Text] [Related]
6. IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy.
Lechner SM; Abbad L; Boedec E; Papista C; Le Stang MB; Moal C; Maillard J; Jamin A; Bex-Coudrat J; Wang Y; Li A; Martini PG; Monteiro RC; Berthelot L
J Am Soc Nephrol; 2016 Sep; 27(9):2622-9. PubMed ID: 26850635
[TBL] [Abstract][Full Text] [Related]
7. Role of IgA receptors in the pathogenesis of IgA nephropathy.
Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
[TBL] [Abstract][Full Text] [Related]
8. [Haemophilus parainfluenzae antigens in IgA nephropathy].
Suzuki S; Kimura H; Gejyo F
Rinsho Byori; 1998 Jan; 46(1):17-25. PubMed ID: 9492534
[TBL] [Abstract][Full Text] [Related]
9. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
Hiki Y; Ito A; Yamamoto Y; Yamamoto K; Iwase H
Adv Otorhinolaryngol; 2011; 72():68-70. PubMed ID: 21865693
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin A1 protease: a new therapeutic candidate for immunoglobulin A nephropathy.
Xie LS; Huang J; Qin W; Fan JM
Nephrology (Carlton); 2010 Aug; 15(5):584-6. PubMed ID: 20649880
[TBL] [Abstract][Full Text] [Related]
11. Cloning and Expression of H. influenzae 49247 IgA Protease in E. coli.
Wang H; Zhong X; Li J; Zhu M; Wang L; Ji X; Fan J; Wang L
Mol Biotechnol; 2018 Feb; 60(2):134-140. PubMed ID: 29318516
[TBL] [Abstract][Full Text] [Related]
12. Renal deposition and clearance of recombinant poly-IgA complexes in a model of IgA nephropathy.
Xie X; Liu P; Gao L; Zhang X; Lan P; Bijol V; Lv J; Zhang H; Jin J
J Pathol; 2021 Jun; 254(2):159-172. PubMed ID: 33660264
[TBL] [Abstract][Full Text] [Related]
13. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
14. Glomerular electron-dense deposits in childhood IgA nephropathy.
Yoshikawa N; Ito H; Nakahara C; Yoshiara S; Yoshiya K; Matsuo T; Hasegawa O; Hazikano H; Okada S
Virchows Arch A Pathol Anat Histopathol; 1985; 406(1):33-43. PubMed ID: 3158115
[TBL] [Abstract][Full Text] [Related]
15. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
Chen A; Sheu LF; Ding SL; Lee WH
Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
[TBL] [Abstract][Full Text] [Related]
16. IgA nephropathy: lessons from an animal model, the ddY mouse.
Tomino Y
J Nephrol; 2008; 21(4):463-7. PubMed ID: 18651534
[TBL] [Abstract][Full Text] [Related]
17. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
Moldoveanu Z; Suzuki H; Reily C; Satake K; Novak L; Xu N; Huang ZQ; Knoppova B; Khan A; Hall S; Yanagawa H; Brown R; Winstead CJ; O'Quinn DB; Weinmann A; Gharavi AG; Kiryluk K; Julian BA; Weaver CT; Suzuki Y; Novak J
J Autoimmun; 2021 Mar; 118():102593. PubMed ID: 33508637
[TBL] [Abstract][Full Text] [Related]
18. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
[TBL] [Abstract][Full Text] [Related]
19. Elution of IgA from kidney tissues exhibiting glomerular IgA deposition and analysis of antibody specificity.
Ogawa Y; Ishizu A; Ishikura H; Yoshiki T
Pathobiology; 2002-2003; 70(2):98-102. PubMed ID: 12476035
[TBL] [Abstract][Full Text] [Related]
20. IgA glycosylation and immune complex formation in IgAN.
Suzuki H; Novak J
Semin Immunopathol; 2021 Oct; 43(5):669-678. PubMed ID: 34570260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
